{
    "data": [
        {
            "id": "6903b1dbecb8a7000145b399",
            "title": "JPMorgan CEO Jamie Dimon Once Called Bitcoin A &#39;Pet Rock&#39; — Now He Says Crypto, Stablecoins Are &#39;Real, We&#39;ll All Use Them&#39;",
            "description": "<div><div class=\"sc-fxwyg khStwV\"><!--$--><p class=\"block core-block\"><strong>JPMorgan Chase </strong>(NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/JPM\" target=\"_blank\">JPM</a>) CEO <a href=\"https://www.benzinga.com/markets/large-cap/25/10/48305691/dimon-warns-credit-risk-treasury-bonds-return-portfolio-protection\" target=\"_blank\">and longtime</a> <strong>Bitcoin</strong> (CRYPTO: <a class=\"ticker\" href=\"https://www.benzinga.com/quote/btc/usd\" target=\"_blank\">BTC</a>) critic<strong> Jamie Dimon</strong> has acknowledged that crypto, blockchain, and stablecoins are \"real.\" </p><!--/$--><!--$--><p class=\"block core-block\">This marks a notable shift in tone as his bank <a href=\"https://www.benzinga.com/crypto/cryptocurrency/25/10/48404937/pet-rock-no-more-jpmorgan-to-accept-bitcoin-ethereum-as-collateral\" target=\"_blank\">prepares to let institutional clients</a> use Bitcoin and <strong>Ethereum</strong> (CRYPTO: <a class=\"ticker\" href=\"https://www.benzinga.com/quote/eth/usd\" target=\"_blank\">ETH</a>) as loan collateral by the end of 2025.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\"><strong>What Happened: </strong>Speaking at Saudi Arabia's Mega Investment Summit in a <a href=\"https://www.youtube.com/watch?v=LITFYkdIRW4\" target=\"_blank\">discussion</a> between Goldman, JPMorgan, BlackRock, Dimon said, \"Crypto is real. Blockchain is real. Stablecoins are real.\"</p><!--/$--><!--$--><p class=\"block core-block\">He added that JPMorgan already operates a deposit coin and uses smart contracts to improve transaction efficiency and customer service, noting, \"It will be used by all of us.\"</p><!--/$--><!--$--><p class=\"block core-block\">JPMorgan recently launched a pilot for its Deposit Token, a blockchain-based payment instrument representing real customer deposits. </p><!--/$--><!--$--><div class=\"sc-SfCGz ciVbir\"></div><!--/$--><!--$--><p class=\"block core-block\">Unlike traditional stablecoins, these tokens are interest-bearing and fully backed by bank liabilities, running on <strong>Coinbase</strong>'s Base network.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Also Read: <a href=\"https://www.benzinga.com/crypto/cryptocurrency/25/10/48536680/bitcoin-ethereum-slide-another-3-is-us-demand-disappearing\" target=\"_blank\">Bitcoin, Ethereum Slide Another 3%: Is US Demand Disappearing?</a></strong></p><!--/$--><!--$--><p class=\"block core-block\"><strong>Why It Matters: </strong>Dimon <a href=\"https://www.youtube.com/watch?v=OoV4riDZW_U\" target=\"_blank\">clarified</a> at a recent Fortune Most Powerful Women Summit in Washington, D.C. that JPMorgan's blockchain is private, allowing the bank full control over permissions and governance, unlike decentralized chains such as Bitcoin or Ethereum that have complete control of who uses the chain.</p><!--/$--><!--$--><div class=\"nativo-placement-in-content-ap\"></div><!--/$--><!--$--><p class=\"block core-block\">The bank's upcoming collateralization program, expected to go live by late 2025, will let institutional clients pledge BTC and ETH for secured loans, marking one of Wall Street's most direct integrations of digital assets into traditional finance.</p><!--/$--><!--$--><div><div><div class=\"bz-campaign bz-campaign-bottom-48540185\" data-nosnippet=\"true\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div><div class=\"flex sm:hidden flex-col\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div></div></div></div></div><!--/$--><!--$--><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong><a href=\"https://www.benzinga.com/crypto/cryptocurrency/25/10/48525742/bitcoin-plummets-below-109000-after-fed-rate-cut-classic-buy-the-rumor-sell-the-news-reaction\" target=\"_blank\">Bitcoin Plummets Below $109,000 After Fed Rate Cut — Classic ‘Buy The Rumor, Sell The News’ Reaction?</a></strong></li>\n</ul><!--/$--><!--$--><p class=\"block core-block\"><em>Image: Shutterstock</em></p><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2025/10/30/JPMorgan-Chase--Co-.jpeg",
            "link": "https://www.benzinga.com/crypto/cryptocurrency/25/10/48540185/jpmorgan-ceo-jamie-dimon-once-called-bitcoin-a-pet-rock-now-he-says-crypto-stablecoins-are-real-well-all-use-them",
            "pub_date": "2025-10-31 02:43:43",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "6903b204ecb8a7000145b3b9",
            "title": "What&#39;s Going On With The Uptick In Core Scientific Stock?",
            "description": "<div><div class=\"sc-fxwyg khStwV\"><!--$--><p class=\"block core-block\"><strong>Core Scientific Inc</strong> (NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/CORZ\" target=\"_blank\">CORZ</a>) shares are moving upward on Thursday. The company announced that it has terminated its merger <a href=\"https://www.benzinga.com/node/48530376\" target=\"_blank\">agreement with <strong>CoreWeave Inc</strong> (NASDAQ:</a><a class=\"ticker\" href=\"https://www.benzinga.com/quote/CRWV\" target=\"_blank\">CRWV</a>)<!-- -->.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>What To Know:</strong> On Oct. 30, 2025, Core Scientific terminated the merger agreement with CoreWeave, effective immediately. The digital company that runs data centers and mines cryptocurrency previously announced that at a special meeting of Core Scientific stockholders, the Company did not receive the votes necessary to approve the previously announced merger deal with CoreWeave.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">The company will stay publicly traded, with its shares continuing to trade on Nasdaq under the ticker symbol CORZ.</p><!--/$--><!--$--><h3 class=\"wp-block-heading\"><strong>CORZ Analysis</strong></h3><!--/$--><!--$--><p class=\"block core-block\">The stock is trading about 26.9% above its 50-day average and 68% above its 200-day average, showing strong upward momentum. This suggests investors are buying in, though the RSI at 67.98 indicates it's not yet in overbought territory.</p><!--/$--><!--$--><div class=\"sc-SfCGz ciVbir\"></div><!--/$--><!--$--><p class=\"block core-block\">The stock has a support level at $18.27, which could help steady it if prices dip. With no clear resistance ahead, traders are eyeing the 52-week high of $22.12 as the next big hurdle — and breaking past it could lead to more gains.</p><!--/$--><!--$--><p class=\"block core-block\">Core Scientific, valued at $6.44 billion, is one of the bigger names in its space and stands to benefit from current market trends. Its recent price movement shows investors are feeling confident, and all eyes are on whether that momentum can hold.</p><!--/$--><!--$--><p class=\"block core-block\">The current setup suggests that a breakout above the 52-week high could lead to increased buying pressure, while a drop below the support level of $18.27 might prompt caution among investors. Traders should keep a close eye on these levels as they could dictate the stock’s short-term trajectory.</p><!--/$--><!--$--><div class=\"nativo-placement-in-content-ap\"></div><!--/$--><!--$--><p class=\"block core-block\"><strong>CORZ Price Action:</strong> <a href=\"https://www.benzinga.com/quote/CORZ\" target=\"_blank\">Core shares</a> were up 0.79% at $20.94 at the time of publication on Thursday, per <a href=\"https://pro.benzinga.com/dashboard?new_user=False&amp;backend=google-oauth2\" target=\"_blank\">Benzinga Pro</a>. The stock is approaching its 52-week high of $22.12, reflecting strong momentum as it continues to gain traction in the market. With a year-to-date performance of 47.0%, the stock has demonstrated robust growth, appealing to investors looking for upward trends.</p><!--/$--><!--$--><div><div><div class=\"bz-campaign bz-campaign-bottom-48540213\" data-nosnippet=\"true\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div><div class=\"flex sm:hidden flex-col\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div></div></div></div></div><!--/$--><!--$--><!--/$--><!--$--><p class=\"block core-block\"><br/><em>Image: Shutterstock</em></p><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2025/10/30/Shanghai-china-may-27th-2024core-Scienti.jpeg",
            "link": "https://www.benzinga.com/trading-ideas/movers/25/10/48540213/whats-going-on-with-the-uptick-in-core-scientific-stock",
            "pub_date": "2025-10-31 02:44:23",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "6903b268ecb8a7000145b3e9",
            "title": "Amazon&#39;s New AI Chips Could Unlock Billions In Revenue, Analysts Say",
            "description": "<div><div class=\"sc-fxwyg khStwV\"><!--$--><p class=\"block core-block\"><span style=\"box-sizing:border-box;margin:0px;padding:0px\"><strong>Amazon.com Inc.</strong>'s (NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/AMZN\" target=\"_blank\">AMZN</a>) </span>massive artificial intelligence push took a major step forward as its <a href=\"https://www.benzinga.com/trading-ideas/movers/25/10/48504056/why-is-amazon-stock-trading-up-today\" target=\"_blank\">Project Rainier supercomputer</a>, powered by nearly 500,000 Trainium2 chips, officially went live.</p><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li>AMZN is having a challenging session. <a href=\"https://www.benzinga.com/quote/AMZN\" rel=\"noreferrer noopener\" target=\"_blank\">Get the scoop here.</a></li>\n</ul><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">The new Rainier system marks a turning point for Amazon Web Services, positioning it to capture a larger share of booming AI training and inference demand that could add billions in revenue growth through 2026.</p><!--/$--><!--$--><p class=\"block core-block\">Bank of America Securities analyst Justin Post maintained a Buy rating on Amazon with a price forecast of $272.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Also Read: <a href=\"https://www.benzinga.com/analyst-stock-ratings/reiteration/25/10/48412764/amazon-poised-for-big-2026-breakout-says-analyst\" rel=\"noreferrer noopener\" target=\"_blank\">Amazon Poised For Big 2026 Breakout, Says Analyst</a></strong></p><!--/$--><!--$--><p class=\"block core-block\">Post said Amazon's Project Rainier, one of the world's largest AI training computers, is now operational.</p><!--/$--><!--$--><div class=\"sc-eQzVdq kfhAgV\"></div><!--/$--><!--$--><p class=\"block core-block\">The system, built with nearly 500,000 Trainium2 chips across multiple U.S. data centers, connects tens of thousands of UltraServers using NeuronLinks to minimize latency. Amazon stated that its AI partner, Anthropic, will gain over five times the compute power it had before, with its Claude model expected to run on more than one million Trainium2 chips by the end of 2025. The analyst noted that while the launch arrived about a month later than expected, it confirms that Amazon's large-scale capacity ramp for AI workloads has begun.</p><!--/$--><!--$--><p class=\"block core-block\">He added that the new Rainier capacity could significantly strengthen AWS through 2026.</p><!--/$--><!--$--><p class=\"block core-block\">Analysts expect AWS revenue to rise 19% year over year in 2026, slightly faster than 2025's 18%. Post believes that Anthropic's growing AI demand could materially boost AWS results, estimating up to $6 billion in incremental revenue in 2026, potentially adding 4 percentage points to overall growth.</p><!--/$--><!--$--><div class=\"nativo-placement-in-content-ap\"></div><!--/$--><!--$--><p class=\"block core-block\">The analyst described Amazon's investment in proprietary technology — including Trainium chips and Nova models as a critical strategic move to differentiate AWS in the competitive AI market.</p><!--/$--><!--$--><p class=\"block core-block\">AWS CEO <strong>Matt Garman</strong> has said these chips can outperform general-purpose alternatives, and Post noted that Amazon's in-house approach could reduce training and inference costs while lifting AWS margins. Still, he acknowledged that investor skepticism remains over whether demand for Trainium-based systems will expand beyond Anthropic.</p><!--/$--><!--$--><p class=\"block core-block\">Post expects Amazon's upcoming earnings call and its re:Invent conference to highlight the benefits of the Rainier rollout and possibly announce Trainium3, further closing the performance gap with other AI chipmakers. The analyst said customer adoption over the next 18 months will be pivotal in determining whether Trainium becomes a major platform in AI infrastructure or faces limitations in broader appeal.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\"><strong>AMZN Price Action:</strong> Amazon.com shares were down 2.28% at $225.05 at the time of publication on Thursday, <a href=\"https://www.benzinga.com/pro/\" rel=\"noreferrer noopener\" target=\"_blank\">according to Benzinga Pro data</a>.</p><!--/$--><!--$--><div><div><div class=\"bz-campaign bz-campaign-bottom-48540258\" data-nosnippet=\"true\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div><div class=\"flex sm:hidden flex-col\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div></div></div></div></div><!--/$--><!--$--><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong><a href=\"https://www.benzinga.com/analyst-stock-ratings/reiteration/25/10/48359419/amazon-the-next-big-ai-winner-one-analyst-thinks-wall-street-is-wrong\" rel=\"noreferrer noopener\" target=\"_blank\">Is Amazon The Next Big AI Winner? One Analyst Thinks Wall Street Is Wrong</a></strong></li>\n</ul><!--/$--><!--$--><p class=\"block core-block\"><em>Image created using artificial intelligence via DALL-E.</em></p><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2025/10/30/amazon-dall-e.png",
            "link": "https://www.benzinga.com/analyst-stock-ratings/reiteration/25/10/48540258/amazons-new-ai-chips-could-unlock-billions-in-revenue-analysts-say",
            "pub_date": "2025-10-31 02:46:03",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "6903b335ecb8a7000145b48b",
            "title": "MSTR Drops 5% Ahead Of Earnings Call: What&#39;s Going On?",
            "description": "<div><div class=\"sc-fxwyg khStwV\"><!--$--><p class=\"block core-block\"><strong>Strategy Inc.</strong> (NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/MSTR\" target=\"_blank\">MSTR</a>) fell nearly 5% to <a href=\"https://www.benzinga.com/money/strategy-stock-price-prediction\" target=\"_blank\">$263 on Thursday</a>, extending a 40% decline since July as sentiment weakens across <strong>Bitcoin </strong>(CRYPTO: <a class=\"ticker\" href=\"https://www.benzinga.com/quote/btc/usd\" target=\"_blank\">BTC</a>)-linked equities.</p><!--/$--><!--$--><h3 class=\"wp-block-heading\">Analysts Say Oversold MSTR Could Spark $28B S&amp;P 500 Flow Boost</h3><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">Despite the steep slide, 10x Research's <strong>Markus Thielen</strong> <a href=\"https://www.coindesk.com/markets/2025/10/29/michael-saylor-s-strategy-drops-usd18b-in-value-but-a-rebound-may-be-near-10x-research\" target=\"_blank\">argues</a> the stock could be nearing an inflection point ahead of Thursday's earnings report. </p><!--/$--><!--$--><p class=\"block core-block\">He expects the company to post a $3.6 billion profit from mark-to-market gains on its Bitcoin holdings, possibly reigniting speculation over <strong>S&amp;P 500</strong> index inclusion.</p><!--/$--><!--$--><p class=\"block core-block\">\"Inclusion in the index could trigger as much as $28 billion in passive and active fund flows,\" Thielen said, noting that the stock's speculative premium has now vanished. </p><!--/$--><!--$--><div class=\"sc-fzzUx jSgJNL\"></div><!--/$--><!--$--><p class=\"block core-block\">He added that Strategy Inc. valuation now sits close to the value of its Bitcoin reserves, making it potentially more attractive than Bitcoin itself at current levels.</p><!--/$--><!--$--><h3 class=\"wp-block-heading\">Michael Saylor's Bitcoin Bet Shrinks MSTR Market Cap By $18B</h3><!--/$--><!--$--><p class=\"block core-block\">Strategy Inc., led by Executive Chairman <strong>Michael Saylor</strong>, remains the largest corporate holder of Bitcoin. </p><!--/$--><!--$--><div class=\"nativo-placement-in-content-ap\"></div><!--/$--><!--$--><p class=\"block core-block\">Its market capitalization has dropped from over $45 billion to about $27 billion, tracking Bitcoin's decline and waning retail enthusiasm.</p><!--/$--><!--$--><p class=\"block core-block\">The firm's net asset value (mNAV) premium has nearly disappeared, reflecting reduced leverage to Bitcoin upside. </p><!--/$--><!--$--><p class=\"block core-block\">Thielen, who had previously been bearish, said the \"washed-out\" sentiment and upcoming catalysts could mark the start of a recovery cycle.</p><!--/$--><!--$--><h3 class=\"wp-block-heading\">Technical Breakdown Tests $260 Support Zone</h3><!--/$--><!--$--><!--/$--><!--$--><p class=\"block core-block\"><a href=\"https://in.tradingview.com/symbols/NASDAQ-MSTR/\" target=\"_blank\"><em>MSTR Price Analysis (Source: TradingView)</em></a></p><!--/$--><!--$--><p class=\"block core-block\">On the charts, MSTR is testing a crucial support zone near $260, sitting at the lower boundary of a symmetrical triangle that has constrained price action since mid-2025.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">The 20-day EMA at $297 and 50-day EMA at $320 now act as overhead resistance, while the 200-day EMA at $338 caps the broader downtrend. </p><!--/$--><!--$--><p class=\"block core-block\">A decisive break below $260 could open the path toward $240–$230, levels last seen before its 2024 rally.</p><!--/$--><!--$--><p class=\"block core-block\">The Supertrend indicator has flipped bearish near $310, adding pressure on buyers to defend this level. </p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">Conversely, a move back above $305–$320 could signal recovery and reestablish the bullish trajectory toward $350 and $387 Fibonacci resistance.</p><!--/$--><!--$--><div><div><div class=\"bz-campaign bz-campaign-bottom-48540404\" data-nosnippet=\"true\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div><div class=\"flex sm:hidden flex-col\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div></div></div></div></div><!--/$--><!--$--><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong><a href=\"https://www.benzinga.com/Opinion/25/10/48536321/a-must-see-chart-for-those-in-the-ai-trade-trump-xi-meeting-amazing\" target=\"_blank\">A Must See Chart for Those in the AI Trade; Trump Xi Meeting ‘Amazing’</a></strong></li>\n</ul><!--/$--><!--$--><p class=\"block core-block\"><em>Image: Shutterstock</em></p><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2025/10/30/Apex--North-Carolina---May-7-2025-Strate.jpeg",
            "link": "https://www.benzinga.com/crypto/cryptocurrency/25/10/48540404/mstr-drops-5-ahead-of-earnings-call-whats-going-on",
            "pub_date": "2025-10-31 02:49:29",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "6903b471ecb8a7000145b534",
            "title": "Baxter Trims Annual Outlook Again, Stock Hits 52-Week",
            "description": "<div><div class=\"sc-fxwyg khStwV\"><!--$--><p class=\"block core-block\"><strong>Baxter International Inc.</strong> (NYSE:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/BAX\" target=\"_blank\">BAX</a>) stock hit a 52-week low on Thursday, after the company again <a href=\"https://www.benzinga.com/pressreleases/25/10/b48522881/baxter-reports-third-quarter-2025-results\" rel=\"noreferrer noopener\" target=\"_blank\">lowered its 2025 guidance</a>.</p><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong><em>BAX stock is at key technical levels. <a href=\"https://www.benzinga.com/quote/BAX\" rel=\"noreferrer noopener\" target=\"_blank\">See the trading setup here</a></em></strong></li>\n</ul><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">Baxter reported a third-quarter adjusted EPS of 69 cents, surpassing the management guidance of 58-62 cents and the <a href=\"https://www.benzinga.com/calendars/earnings\" rel=\"noreferrer noopener\" target=\"_blank\">Wall Street estimate of 60 cents</a>.</p><!--/$--><!--$--><p class=\"block core-block\">The medical device maker reported sales of $2.84 billion, up 5% year-over-year on a reported basis and 2% on an operational basis. That's almost in line with the consensus of $2.88 billion.</p><!--/$--><!--$--><p class=\"block core-block\"><strong><em>Also Read: <a href=\"https://www.benzinga.com/markets/large-cap/25/09/47874551/trump-administration-commerce-department-investigation-targets-ppe\" rel=\"noreferrer noopener\" target=\"_blank\">Trump Administration Review Targets Medical Supply Chain Vulnerabilities</a></em></strong></p><!--/$--><!--$--><p class=\"block core-block\">Management expected third-quarter sales growth of 6% to 7% on a reported basis and <a href=\"https://www.benzinga.com/markets/earnings/25/07/46768547/baxter-stock-plunges-to-52-week-low-on-trimmed-annual-outlook\" rel=\"noreferrer noopener\" target=\"_blank\">3% to 4% on an operational basis</a>.</p><!--/$--><!--$--><div class=\"sc-fzzUx jSgJNL\"></div><!--/$--><!--$--><p class=\"block core-block\"><strong>Medical Products &amp; Therapies</strong> sales were approximately $1.33 billion, declining 1% on both a reported and operational basis. The decline reflected reduced sales within the Infusion Therapies &amp; Technologies division, partially offset by strong global demand for Advanced Surgery products.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Healthcare Systems &amp; Technologies </strong>sales were $773 million, an increase of 3% on a reported basis and 2% on an operational basis, reflecting demand for Care &amp; Connectivity Solutions products.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Pharmaceutical </strong>sales totaled approximately $632 million, an increase of 7% on a reported basis and 7% on an operational basis. Performance in the quarter reflected continued strength in Drug Compounding and Injectables &amp; Anesthesia products.</p><!--/$--><!--$--><div class=\"nativo-placement-in-content-ap\"></div><!--/$--><!--$--><h2 class=\"wp-block-heading\">Guidance</h2><!--/$--><!--$--><p class=\"block core-block\">Baxter has cut its fiscal 2025 adjusted earnings guidance from $2.42-$2.52 per share to $2.35-$2.40 per share, compared to the <a href=\"https://www.benzinga.com/calendars/guidance\" rel=\"noreferrer noopener\" target=\"_blank\">consensus of $2.44</a>.</p><!--/$--><!--$--><p class=\"block core-block\">The hospital product maker lowered its 2025 sales guidance from $11.27 billion to $11.38 billion to $11.06 billion to $11.17 billion, compared to the consensus of $11.31 billion.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">Baxter expects sales growth of 4%-5% (down from a prior range of 6%-7%) on a reported basis, and 1%-2% on an operational basis, compared to the previously expected 3%-4 %.</p><!--/$--><!--$--><p class=\"block core-block\">Baxter expects fourth quarter adjusted earnings of 52-57 cents versus the consensus of 70 cents.</p><!--/$--><!--$--><p class=\"block core-block\">The company expects sales growth of approximately 2% on a reported basis and a decline of approximately 2% on an operational basis.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\"><strong>BAX Price Action:</strong> Baxter Intl shares were down 13.31% at $19.43 at the time of publication on Thursday. The stock is trading near its 52-week low of $21.33, <a href=\"https://www.benzinga.com/pro/\" rel=\"noreferrer noopener\" target=\"_blank\">according to Benzinga Pro data</a>.</p><!--/$--><!--$--><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong><em><a href=\"https://www.benzinga.com/node/48539871\" rel=\"noreferrer noopener\" target=\"_blank\">Cigna Forecasts Two-Year Margin Strain In Pharmacy Benefit Unit, Stock Tanks</a></em></strong></li>\n</ul><!--/$--><!--$--><p class=\"block core-block\"><em>Photo via Shutterstock</em></p><!--/$--><!--$--><div><div><div class=\"bz-campaign bz-campaign-bottom-48540569\" data-nosnippet=\"true\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div><div class=\"flex sm:hidden flex-col\"><div class=\"sc-c014f608-0 kUPEDz skeleton min-h-[inherit] animate-pulse variant\" role=\"status\"><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div><div class=\"skeleton-child\"></div></div></div></div></div></div><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2025/10/30/Stuttgart--Germany---03-31-2023-Person-H.jpeg",
            "link": "https://www.benzinga.com/markets/earnings/25/10/48540569/baxter-trims-annual-outlook-again-stock-hits-52-week",
            "pub_date": "2025-10-31 02:54:44",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        }
    ]
}